Supplement Material
Jujube cAMP
Finished Product
Fermented Drinks
FSMP
Sports Nutrition Supplements
PKU Health Care Activities
CKD Health Care Activities
Leave Your Message
Explore SINOFN's core dosage form product lines — each formulated to maximize bioavailability, efficacy, and consumer experience for athletic performance and recovery applications.
A suspension dosage form is a liquid preparation in which finely divided, insoluble active ingredients are uniformly dispersed throughout a liquid vehicle. In the context of sports nutrition and athletic supplementation, this technology enables the delivery of high-potency compounds — including creatine, branched-chain amino acids (BCAAs), beta-alanine, collagen peptides, and herbal adaptogens — with superior bioavailability compared to conventional solid forms.
Unlike tablets or standard capsules, suspension dosage forms bypass the dissolution step required for solid formulations, allowing active compounds to enter the gastrointestinal tract in a pre-dispersed state. Clinical studies suggest that suspension-based nutrient delivery can achieve plasma peak concentrations up to 35% faster than equivalent solid forms — a critical advantage for pre-workout, intra-workout, and post-workout supplementation windows where timing directly impacts muscle protein synthesis, glycogen replenishment, and recovery kinetics.
Modern suspension formulations employ advanced particle engineering technologies — including nano-milling, microencapsulation, and controlled-release polymer systems — to stabilize active ingredients against sedimentation, oxidation, and pH degradation. Suspending agents such as xanthan gum, carboxymethylcellulose (CMC), and hydroxypropyl methylcellulose (HPMC) are carefully selected to maintain uniform dispersion, optimize viscosity, and ensure dose reproducibility batch after batch.
For athletes, the science of supplementation timing is just as important as the chemistry of the compounds themselves. Suspension forms are uniquely positioned to serve multiple supplementation windows: the pre-workout phase (enhancing energy substrate availability), the intra-workout phase (sustaining electrolyte balance and reducing fatigue), and the critical post-workout recovery phase (accelerating muscle repair via rapid amino acid delivery). This versatility makes suspension formulations the preferred format for elite sports nutrition brands globally.
The global sports nutrition market surpassed USD 47 billion in 2024 and is forecast to exceed USD 85 billion by 2032, with liquid and suspension dosage forms representing one of the fastest-growing segments driven by consumer demand for faster-acting, more bioavailable formulations.
The suspension dosage form sector is undergoing rapid transformation driven by converging forces in consumer behavior, regulatory evolution, and manufacturing technology. Below are the key trends reshaping the landscape for athletic performance and recovery product development.
Next-generation nano-suspension technologies are enabling ingredient particle sizes below 1,000 nm, dramatically enhancing the saturation solubility and dissolution velocity of poorly water-soluble actives. For sports ingredients like CoQ10, curcumin, and fat-soluble vitamins D3/K2, nano-suspension processing can increase oral bioavailability by 200–400% compared to conventional formulations — a game-changer for recovery-focused supplement brands seeking clinical differentiation.
Innovative packaging formats — including dual-chamber bottles, bi-phase sachets, and pre-filled suspension syringes — are revolutionizing how suspension supplements reach the end consumer. These formats maintain physical separation of incompatible actives until the point of consumption, extending product shelf life, preserving potency, and creating powerful on-shelf visual differentiation for sports nutrition brands competing in crowded retail environments.
Consumer demand for clean-label formulations is accelerating the development of plant-derived suspending agents. Acacia gum, chia seed mucilage, and modified starch systems are replacing synthetic polymer excipients in premium sports nutrition lines. Simultaneously, the rise of vegan and vegetarian athletic demographics is driving reformulation of suspension products to eliminate animal-derived stabilizers, creating significant OEM opportunities for manufacturers with plant-based formulation expertise.
Artificial intelligence and machine learning are being applied to suspension formulation development — predicting optimal excipient combinations, stability profiles, and sensory attributes from vast experimental datasets. Simultaneously, continuous manufacturing platforms are replacing batch production for suspension liquids, enabling real-time quality control, reduced cycle times, and lower minimum order quantities — directly benefiting sports nutrition brands seeking agile, cost-competitive contract manufacturing partnerships.
From elite professional sports to everyday active consumers, suspension dosage forms are finding increasingly specialized applications across the entire athletic performance and recovery ecosystem. Here we analyze the most commercially significant use cases.
Pre-workout suspension products deliver a complex matrix of performance-enhancing compounds — caffeine, beta-alanine, citrulline malate, nitric oxide precursors — in a rapidly absorbing liquid form. Suspension technology allows high-dose active loading without the gastric distress associated with concentrated liquid drinks, while achieving plasma peak levels 20–30 minutes faster than capsule equivalents. This timing advantage directly translates to optimized neuromuscular activation during training sessions.
Advanced intra-workout suspension products combine electrolytes (sodium, potassium, magnesium) with rapidly absorbable carbohydrate matrices and branched-chain amino acids in a single, shelf-stable suspension format. The suspension vehicle maintains mineral ion bioavailability far superior to compressed tablet formats, enabling sustained hydration and muscle contraction support throughout extended training sessions. Key markets include endurance sports, team sports, and high-intensity interval training communities.
Post-workout recovery represents the highest-value application segment for athletic suspension formulations. Products in this category leverage suspension technology to co-deliver hydrolyzed whey protein, collagen peptides, glutamine, HMB (beta-hydroxy beta-methylbutyrate), and anti-inflammatory compounds (such as tart cherry extract and curcumin nano-suspension) within the critical 30-minute anabolic window. The suspension format enables ingredient combinations that would be physically impossible in solid dosage forms due to solubility incompatibilities.
The convergence of sports performance and cognitive enhancement is driving demand for suspension products incorporating adaptogenic botanicals — ashwagandha (KSM-66), Rhodiola rosea, lion's mane mushroom, and phosphatidylserine. These compounds present significant solubility challenges in solid formats, but suspension technology enables full-dose delivery of these complex phytochemical matrices. The resulting "mind-muscle" products are capturing significant market share among competitive esports athletes, military personnel, and high-performance executives.
Long-term athletic participation places extreme mechanical stress on joints, tendons, and connective tissues. Suspension formulations are particularly valuable for delivering type II collagen, hyaluronic acid, glucosamine sulfate, and chondroitin — compounds that require specific particle size distribution for optimal gastrointestinal absorption. Clinical evidence supports that collagen peptide suspension formulations achieve significantly higher plasma hydroxyproline levels compared to solid collagen capsules, translating to measurably improved joint health outcomes in active populations.
Nighttime recovery represents an emerging and commercially exciting application for suspension dosage forms. Products combining slow-release casein micelle suspensions with sleep-supporting compounds (magnesium glycinate, melatonin, L-theanine, ashwagandha) leverage suspension technology to achieve controlled release kinetics over 6–8 hours. For athletes with multiple-sessions-per-day training schedules, optimizing the sleep phase represents the single largest untapped recovery opportunity — and suspension formats are uniquely equipped to serve it.
Pre-dispersed active particles bypass dissolution barriers, enabling faster systemic absorption and higher peak plasma concentrations — critical for time-sensitive supplementation windows in athletic contexts.
Suspension vehicles can accommodate multiple actives with different solubility profiles in a single dose — enabling synergistic combinations impossible in solid forms, and reducing consumer pill burden.
Suspension technology accommodates high-load actives, heat-sensitive compounds, and novel bioactives that would degrade during conventional tablet compression or capsule filling processes.
Advanced suspending systems and manufacturing controls ensure uniform active distribution throughout the suspension matrix, delivering consistent doses batch-to-batch — essential for clinical-grade sports nutrition products.
Suspension products offer palatability advantages over powders and solids, with customizable flavor systems, texture profiles, and color aesthetics that align with premium sports nutrition brand positioning strategies.
Suspension dosage forms can be registered and marketed across multiple regulatory frameworks — dietary supplement, functional food, nutraceutical, and medical food categories — providing maximum market access flexibility for global sports nutrition brands.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group — a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
Sinofn prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety in every suspension dosage form we manufacture.
GMP-Certified Supplement Manufacturing — From Formula to Finished Goods. With state-of-the-art manufacturing facilities, specialized R&D capabilities, and a robust supply chain, we ensure the highest quality standards for every suspension product we produce.
State-of-the-art GMP-certified suspension manufacturing lines with real-time QC monitoring and full batch traceability.
Backed by the Chinese Academy of Sciences with dedicated formulation scientists specializing in suspension stability and bioavailability optimization.
Full regulatory documentation support for suspension dosage form products across US, EU, AU, Southeast Asia, and Middle East market requirements.
Vetted raw material suppliers, transparent sourcing documentation, and global logistics partnerships ensuring on-time delivery to any market.
Complete turnkey packaging design and production services — from suspension bottle selection to label design and secondary packaging for retail-ready athletic products.
Agile suspension formula development with prototype turnaround in as few as 15 business days and scalable MOQs suitable for emerging sports nutrition brands.
Robust IP portfolio protecting proprietary suspension delivery technologies and formulation innovations developed for athletic performance applications.
Shanghai-based trading team providing single-point-of-contact project management for international OEM clients across every stage of the suspension product lifecycle.
Welcome to our world of suspension supplement manufacturing expertise. We are committed to delivering premium quality suspension dosage form products tailored to meet your brand's specific athletic performance and recovery needs — from initial concept through to shelf-ready finished goods.
Every SINOFN suspension formula begins with a rigorous literature review and ingredient compatibility analysis conducted by our in-house team of pharmaceutical scientists. We evaluate particle size distribution, zeta potential, rheological properties, and accelerated stability data before advancing any suspension formula to pilot batch production — ensuring every product we commercialize performs as intended throughout its shelf life under real-world storage conditions.
SINOFN's manufacturing infrastructure supports seamless scale-up from prototype suspension batches to full commercial production volumes without formula variation. Our process validation protocols, inline viscosity monitoring, and automated filling systems guarantee that the suspension product your customers receive is identical to the prototype that earned their trust — batch after batch, year after year, at any production volume your brand requires.
From pre-workout suspension blends to post-workout recovery systems, our full product catalog covers every performance and recovery need — each available as a fully customizable OEM suspension dosage form.
Partner with SINOFN Health — where pharmaceutical-grade suspension manufacturing science meets world-class sports nutrition innovation. From concept to commercial launch, our team is ready to deliver your custom suspension formula on time, on spec, and on brand.
Explore SINOFN's Suspension Solutions →